Cox regression models were used to evaluate the association between baseline Aβ38 levels and risk of AD dementia in AD biomarker–positive individuals (AD+; determined by CSF phosphorylated tau [P-tau]/Aβ42 ratio) with subjective cognitive decline (SCD) or mild cognitive impairment (MCI). This evidence concerns the gene MAPT and Schnyder corneal dystrophy.